These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26196325)

  • 1. Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells.
    Fischer WA; King LS; Lane AP; Pekosz A
    Vaccine; 2015 Aug; 33(36):4495-504. PubMed ID: 26196325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.
    Fischer WA; Chason KD; Brighton M; Jaspers I
    Vaccine; 2014 Mar; 32(15):1761-7. PubMed ID: 24486351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.
    Wohlgemuth N; Ye Y; Fenstermacher KJ; Liu H; Lane AP; Pekosz A
    Vaccine; 2017 Dec; 35(48 Pt B):6691-6699. PubMed ID: 29079099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.
    Forero A; Fenstermacher K; Wohlgemuth N; Nishida A; Carter V; Smith EA; Peng X; Hayes M; Francis D; Treanor J; Morrison J; Klein SL; Lane A; Katze MG; Pekosz A
    Vaccine; 2017 Oct; 35(45):6112-6121. PubMed ID: 28967519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures.
    Canaday LM; Resnick JD; Liu H; Powell H; McCoy AM; Nguyen D; Pekosz A
    Vaccine; 2022 Jul; 40(32):4544-4553. PubMed ID: 35718589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
    Powell H; Liu H; Pekosz A
    Vaccine; 2021 Jun; 39(24):3225-3235. PubMed ID: 33985852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of MDCK cells for production of live attenuated influenza vaccine.
    Liu J; Shi X; Schwartz R; Kemble G
    Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness.
    Hawksworth A; Lockhart R; Crowe J; Maeso R; Ritter L; Dibben O; Bright H
    Vaccine; 2020 May; 38(26):4209-4218. PubMed ID: 32376111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
    Cherukuri A; Servat E; Woo J
    Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
    Hussain AI; Cordeiro M; Sevilla E; Liu J
    Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium.
    Ilyushina NA; Ikizler MR; Kawaoka Y; Rudenko LG; Treanor JJ; Subbarao K; Wright PF
    J Virol; 2012 Nov; 86(21):11725-34. PubMed ID: 22915797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase.
    Mori K; Ohniwa RL; Takizawa N; Naito T; Saito M
    J Virol; 2021 May; 95(12):. PubMed ID: 33827947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
    King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
    J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
    Ayaz S; Dibben O; Chapman D
    Vaccine; 2021 Nov; 39(46):6735-6745. PubMed ID: 34663504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine.
    Ambrose CS; Wu X; Jones T; Mallory RM
    Vaccine; 2012 Nov; 30(48):6794-801. PubMed ID: 23000125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.
    Chan W; Zhou H; Kemble G; Jin H
    Virology; 2008 Oct; 380(2):304-11. PubMed ID: 18768193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.